Trends in FDA approval of oncology drugs: have we made progress?

Chan, John

190
Trends in FDA approval of oncology drugs: have we made progress?

Saturday, March 28, 2015: 9:55 AM

Salon C-D (Hilton Chicago)

N. Young-Lin¹, K. Blansit², A. B. Gardner², J. S. Chapman¹, D. S. Kapp³ and J. K. Chan⁴
¹UCSF Helen Diller Comprehensive Cancer Center, San Francisco, CA, ²Palo Alto Medical Foundation Research Institute, Palo Alto, CA, ³Stanford University, Stanford, CA, ⁴California Pacific & Palo Alto Medical Foundation / Sutter Research Institute, San Francisco, CA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

190
Trends in FDA approval of oncology drugs: have we made progress?

190 Trends in FDA approval of oncology drugs: have we made progress?

190
Trends in FDA approval of oncology drugs: have we made progress?